From Theory to Practice: Bone Health in Women with Early Breast Cancer Treated with Aromatase Inhibitors

Aromatase inhibitors (AI) are extensively used as adjuvant endocrine therapy in post-menopausal women with hormone receptor-positive early breast cancer (HR+ EBC), but their impact on bone health is not negligible. This work aimed to assess bone loss, fracture incidence, and risk factors associated...

Полное описание

Сохранить в:
Библиографические подробности
Опубликовано в: :Curr Oncol
Главные авторы: Vasconcelos de Matos, Leonor, Fernandes, Leonor, Neves, Maria Teresa, Alves, Fátima, Baleiras, Mafalda, Ferreira, André, Giesteira Cotovio, Pedro, Dias Domingues, Tiago, Malheiro, Mariana, Plácido, Ana, Miranda, Maria Helena, Martins, Ana
Формат: Artigo
Язык:Inglês
Опубликовано: MDPI 2021
Предметы:
Article
Online-ссылка:https://ncbi.nlm.nih.gov/pmc/articles/PMC8025750/
https://ncbi.nlm.nih.gov/pubmed/33652975
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/curroncol28020104
Метки: Добавить метку
Нет меток, Требуется 1-ая метка записи!

Схожие документы